Police constable assaults top official of Belagavi airport

Udupi, Feb 23: Karnataka's minister for Tourism and Culture CT Ravi on Sunday said that India is losing money as because people travel abroad to visit casinos.

Arguing that casinos are being used by countries to promote tourism, he took to Twitter to highlight the issue, saying, "During my interaction with FKCCI, I had mentioned that many countries have promoted Tourism through Casinos. Isn't it a fact that lakhs of Indians go abroad to play in Casinos? Can anyone stop them? At the moment, there is no proposal before Our Govt to set up Casinos here,' he tweeted in the morning.

He also urged the Central government to stop people from visiting abroad.

Yesterday, the minister had stated that he has no intention of developing "casino tourism" in the state.

"I only expressed my opinion on how other countries have promoted tourism, during a discussion. Casino tourism is one such thing, I have no intention of developing it here," Ravi had told media when asked to comment on Karnataka government's proposal of casinos in Coastal Karnataka.

"What I meant was many Indians go and spend there, our money should be spent here itself," he had said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Jul 17: A total of 3,693 new COVID-19 positive cases and 115 deaths were reported in Karnataka on Friday, said the state health department.

The total number of COVID-19 cases in the state is presently at 55,115, including 33,205 active cases. While there are 20,757 recoveries, the death toll stands at 1,147.

With the highest single-day spike of 34,956 cases and 687 deaths, India's COVID-19 positive cases crossed the 10 lakh mark on Friday, according to the Union Ministry of Health and Family Welfare.

The total positive cases stand at 10,03,832 including 3,42,473 active cases, 6,35,757 cured/discharged/migrated and 25,602 deaths, according to the ministry.